Global obesity drug expansion: Lilly and Novo eye growth
The focus is on global obesity drug expansion as Lilly and Novo Nordisk broaden production capacity to meet anticipated growth and wider medical coverage
Most important news & global events daily
The focus is on global obesity drug expansion as Lilly and Novo Nordisk broaden production capacity to meet anticipated growth and wider medical coverage
Your cart is currently empty!
Notifications